A/Prof Lev Kats
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
50 Scholarly works
4 Projects
HIGHLIGHTS
2026
Journal article
Abstract 4501: Targeting the epigenetic adaptor protein menin in multiple myeloma.
DOI: 10.1158/1538-7445.am2026-45012026
Journal article
Discovery and Characterization of VPRBP/DCAF1 Kinase Inhibitor Analogs as Microtubular Destabilizing Agents with Potent Antimyeloma Activity
DOI: 10.1158/1535-7163.MCT-25-03062026
Journal article
Epigenetic reprogramming in multiple myeloma—Challenges and opportunities
DOI: 10.1002/ijc.354262026
Journal article
Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemia
DOI: 10.1016/j.cell.2025.10.0282023
Research grants (ARC, NHMRC, MRFF)
Understanding and Targeting Self-Renewal in Aggressive Blood Cancers
2022
Journal article
Non-genetic determinants of malignant clonal fitness at single-cell resolution
DOI: 10.1038/s41586-021-04206-72020
Research Grant
Rna Methylation in Normal and Malignant Blood Development
RECENT SCHOLARLY WORKS
2025
Journal article
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors
DOI: 10.1038/s41467-025-59021-92025
Journal article
Building a transparent and functional laboratory culture: guidelines for creating a Laboratory Handbook for principal investigators
DOI: 10.1016/j.exphem.2025.1052652025
Journal article
Advice for effective leadership and hitting the ground running as a new group leader
DOI: 10.1016/j.exphem.2024.1046742024
Journal article
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
DOI: 10.1038/s41586-024-07242-12023
Journal article
The curious case of IDH mutant acute myeloid leukaemia: biochemistry and therapeutic approaches
DOI: 10.1042/BST202300172023
Journal article
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphoma
DOI: 10.1073/pnas.2306414120
RECENT PROJECTS
2016
Research Grant
Understanding Response and Resistance to Inhibition of Mutant Isocitrate Dehydrogenase in Acute Myeloid Leukaemia
2014
Research Grant
Exploring the Role of the Tumour Suppressor PML in Maintenance Of Leukaemia Initiating Cells